Skip to main content

Roche’s Virtual Event following Angiogenesis 2021

Roche has hosted a virtual event on Tuesday, 16th February 2021.

agenda
Agenda:
WelcomeKarl Mahler, Head of Investor Relations and Roche Group Planning
Ophthalmology Strategy UpdateAtul Dandekar, Vice President and Global Franchise Head of Ophthalmology Product Strategy
Ophthalmology Pipeline UpdateChristopher Brittain, Vice President and Global Head of Ophthalmology Product Development
Faricimab in DME and nAMD – Phase III resultsNancy Holekamp, M.D., Retina Specialist and Clinical Investigator
Q&A

Webinar Replay

InvestorsPast IR Events
View more Events

Downloads

Download Presentation

PDF

Related links

  • Roche’s Annual Report 2020

    Investors

    How medicines are making an impact in the lives of patients

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions